These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2876342)

  • 1. Cyclosporin, HLA matching, and transfusions in kidney transplants.
    Persijn GG; Schreuder GM; Hendriks GF; Cohen B; D'Amaro J; van Rood JJ
    Lancet; 1986 Oct; 2(8512):915-6. PubMed ID: 2876342
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation--a changing picture with cyclosporin.
    Lundgren G; Groth CG; Albrechtsen D; Brynger H; Flatmark A; Frödin L; Gäbel H; Husberg B; Klintmalm G; Maurer W
    Lancet; 1986 Jul; 2(8498):66-9. PubMed ID: 2873380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the HLA-A, -B, -DR matching effect by cyclosporin therapy.
    Persijn GG; D'Amaro J; de Lange P; Schreuder GM; van Rood JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):656-8. PubMed ID: 2650212
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of HLA matching in renal transplantation.
    Ting A; Morris PJ
    Tissue Antigens; 1985 May; 25(5):225-34. PubMed ID: 3895565
    [No Abstract]   [Full Text] [Related]  

  • 5. DR phenotype matching and transfusion in patients treated with cyclosporine.
    Cicciarelli J; Terasaki PI
    Transplant Proc; 1988 Dec; 20(6):1082-3. PubMed ID: 3201554
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment protocols: is there a role for tissue typing in renal transplantation?
    Ferguson RM
    Transplant Proc; 1988 Dec; 20(6 Suppl 8):42-5. PubMed ID: 3059621
    [No Abstract]   [Full Text] [Related]  

  • 7. Preferential effectiveness of cyclosporin in patients receiving kidney transplants after glomerulonephritis.
    Cats S; Terasaki PI; Perdue S; Mickey MR
    Lancet; 1985 Mar; 1(8427):490-1. PubMed ID: 2857855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA matching and cyclosporin immunosuppression: a strong correlation.
    Cicciarelli J; Terasaki PI; Mickey MR
    Lancet; 1986 Feb; 1(8475):267. PubMed ID: 2868272
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy.
    Vanrenterghem Y; Roels L; Waer M; Gruwez J; Dendievel J; Michielsen P
    Transplant Proc; 1987 Feb; 19(1 Pt 1):685-6. PubMed ID: 3274841
    [No Abstract]   [Full Text] [Related]  

  • 10. The transfusion effect in cadaver kidney transplants--yes or no.
    Iwaki Y; Cecka JM; Terasaki PI
    Transplantation; 1990 Jan; 49(1):56-9. PubMed ID: 2301028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood transfusions and HLA matching--an either/or situation in cadaveric renal transplantation.
    Cecka JM; Cicciarelli J; Mickey MR; Terasaki PI
    Transplantation; 1988 Jan; 45(1):81-6. PubMed ID: 3276068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of center variation on the HLA-DR matching effect in kidney graft survival.
    Thorogood J; van Houwelingen JC; van Rood JJ; Persijn GG
    Transplantation; 1989 Aug; 48(2):231-8. PubMed ID: 2667206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial influence of matching for D/DR antigens and treatment with cyclosporin-A on kidney graft survival in transfused rhesus monkeys.
    Borleffs JC; Marquet RL; Neuhaus P
    Proc Eur Dial Transplant Assoc; 1981; 18():446-53. PubMed ID: 6460246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of HLA matching and lymphocytotoxic antibody status in heart-lung allograft recipients receiving cyclosporin and azathioprine.
    Festenstein H; Banner N; Smith J; Awad J; Burden M; Fitzgerald N; Holmes J; Khaghani A; Smith J; McCloskey D
    Transplant Proc; 1989 Feb; 21(1 Pt 1):797-8. PubMed ID: 2495632
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood transfusions and HLA compatibility in first cadaveric kidney transplants treated with cyclosporine A.
    Garcia LF; Arango AM; Henao JE; Arbelaez M
    Transplant Proc; 1988 Aug; 20(4):715-9. PubMed ID: 3043844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of HLA matching and pretransplant blood transfusions in cyclosporine-treated recipients of cadaveric renal allografts: 2- to 3-year results.
    Lundgren G; Albrechtsen D; Brynger H; Flatmark A; Frödin L; Gäbel H; Lindholm A; Maurer W; Möller E; Persson H
    Transplant Proc; 1987 Oct; 19(5):3614-8. PubMed ID: 3313870
    [No Abstract]   [Full Text] [Related]  

  • 17. Important of HLA matching in cadaveric renal transplantation. A prospective one-center study.
    Moen T; Flatmark A; Jervell J; Dahl O; Halvorsen S; Solheim B; Thorsby E
    Scand J Urol Nephrol Suppl; 1981; 64():64-71. PubMed ID: 6815795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A effective therapy for fifty-two cadaver kidney recipients.
    Takagi H; Uchida K; Ohshima S; Fujita T; Kano T; Asano H; Ono Y
    Jpn J Surg; 1985 Mar; 15(2):160-5. PubMed ID: 3892112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azathioprine and cyclosporin: different tissue matching criteria needed?
    Harris KR; Digard N; Gosling DC; Tate DG; Campbell MJ; Gardner B; Sharman VL; Slapak M
    Lancet; 1985 Oct; 2(8459):802-5. PubMed ID: 2864533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of HLA-matching, cyclosporin-A, and transplant year on annual kidney graft survival.
    Thorogood J; van Houwelingen JC; van Rood JJ; Persijn GG
    Transplant Proc; 1989 Aug; 21(4):3723-4. PubMed ID: 2669284
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.